Cariad Chester
InvestorManaging Partner at TCG Crossover
About
Managing Partner who was previously a Managing Director at Aquilo Capital investing in biotech therapeutics and earlier a cancer research scientist at Stanford. He holds a B.A. from Swarthmore College in Neuroscience and Comparative Religious Studies.
Contact· self-published, not guessed
Deals · 1
Ollin Biosciences, Inc.Board seat
via TCG Crossover · filed Jun 2026 · $330M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Per SEC Form D filings.
Colleagues at TCG Crossover
Bill Zhang
Analyst at TCG Crossover
Bow Papanos
Executive Assistant at TCG Crossover
Brad Balter
Head of Trading at TCG Crossover
Charles Sawyers
Science Partner at TCG Crossover
Charles Zuker
Science Partner at TCG Crossover
Chen Yu
Managing Partner at TCG Crossover
Craig Skaling
COO and CFO at TCG Crossover
Dandan Dong
Venture Partner at TCG Crossover
Frequently asked questions
- Who is Cariad Chester?
- Managing Partner who was previously a Managing Director at Aquilo Capital investing in biotech therapeutics and earlier a cancer research scientist at Stanford. He holds a B.A. from Swarthmore College in Neuroscience and Comparative Religious Studies.
- Where does Cariad Chester work?
- Cariad Chester is Managing Partner at TCG Crossover.
- What boards does Cariad Chester sit on?
- Cariad Chester holds tracked board seats at Ollin Biosciences, Inc., Plexium.








